Reed, M
Dihexa, or N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, first known PNB-0408, is a novel nootropic compound and experimental drug that has been developed for possible treatment of trauma-based brain disorders and neurodegenerative conditions (i.e., Alzheimers, Parkinsons) that would compensate for arisen cognitive deficits through increased synaptogenesis
The results of moderator analyses to explore influential variables indicated that increasing age was associated with increased nocturia, while longer follow-up periods were associated with decreased frequency
Composition: GLUTATHIONE 1200MG IM/IV Glutathione is a powerful antioxidant naturally produced by the body, and when given via intramuscular (IM) injection, it provides direct cellular support to help detoxify, brighten the skin, and reduce oxidative stress
Formulated in Salt Lake City, our products support active lifestyles and whole-body health